BU-NOT-SET

CONTACT US
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Case study
  • Drug product
  • Manufacturing
Accelerating tablet tech-transfer through predictive modelling
Case study
  • Drug product
  • Manufacturing
Tackling assay variability in liquid vials: A data-driven approach to overcoming challenges
Fact sheet
  • Drug product
  • Manufacturing
Scalable solutions for high potent manufacturing
Insight
  • Drug product
  • Manufacturing
The stabilising power of lyophilisation in next-generation therapeutics
Insight
  • Drug product
  • Manufacturing
Unlocking the power of advanced sterile packaging
Fact sheet
  • Biologics
  • Manufacturing
Advancing continuous bioprocessing with Recimagine™
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation